NOTCH2NLC中间长度重复扩增与帕金森病相关
本研究在1011例帕金森病患者中筛查NOTCH2NLC基因GGC重复扩增,发现11例携带41-52次中间长度重复扩增,而1134例对照中无重复扩增。2例携带中间长度重复扩增的患者皮肤活检显示磷酸化α-突触核蛋白沉积,证实帕金森病诊断而非NIID或特发性震颤。携带中间长度重复扩增的帕金森病患者成纤维细胞显示NOTCH2NLC表达上调及自噬功能障碍。
要点
- 帕金森病患者中可检出NOTCH2NLC基因GGC中间长度重复扩增(41-52次)。
- 携带中间长度重复扩增的帕金森病患者皮肤活检可见磷酸化α-突触核蛋白沉积。
- 中间长度重复扩增可能通过NOTCH2NLC上调及自噬功能障碍参与帕金森病。
核心结论
- NOTCH2NLC基因中间长度GGC重复扩增可能与帕金森病相关。
研究设计与样本
- 在1011例帕金森病患者中筛查NOTCH2NLC基因GGC重复扩增,并与1134例对照比较。
主要发现
- 11例帕金森病患者携带41-52次中间长度重复扩增,1134例对照中无重复扩增。
- 2例携带中间长度重复扩增的患者皮肤活检显示磷酸化α-突触核蛋白沉积,证实帕金森病诊断。
- 携带中间长度重复扩增的帕金森病患者成纤维细胞显示NOTCH2NLC表达上调及自噬功能障碍。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
NOTCH2NLC GGC repeat expansions were recently identified in neuronal intranuclear inclusion disease (NIID); however, it remains unclear whether they occur in other neurodegenerative disorders. This study aimed to investigate the role of intermediate-length NOTCH2NLC GGC repeat expansions in Parkinson disease (PD). We screened for GGC repeat expansions in a cohort of 1,011 PD patients and identified 11 patients with intermediate-length repeat expansions ranging from 41 to 52 repeats, with no repeat expansions in 1,134 controls. Skin biopsy revealed phospho-alpha-synuclein deposition, confirming the PD diagnosis in 2 patients harboring intermediate-length repeat expansions instead of NIID or essential tremor. Fibroblasts from PD patients harboring intermediate-length repeat expansions revealed NOTCH2NLC upregulation and autophagic dysfunction. Our results suggest that intermediate-length repeat expansions in NOTCH2NLC are potentially associated with PD. ANN NEUROL 2021;89:182-187.
引用
- Shi CH, Fan Y, Yang J, et al. NOTCH2NLC Intermediate-Length Repeat Expansions Are Associated with Parkinson Disease. Ann Neurol. 2020. PMID: 33016348. doi:10.1002/ana.25925
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。